Tactile Systems Technology Stock Price and Value Analysis

Tactile Systems Technology (NasdaqGM:TCMD) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Tactile Systems Technology to reach your target.

Target type

TCMD Free Cash Flow Trend

Free Cash Flow trendline for TCMD
Free Cash Flow trendline for Tactile Systems Technology
CSV

Based on historical returns, we believe that Tactile Systems Technology can grow its free cash at a rate of about 6%. That's positive!

AdvantagesDisadvantagesNeutral
  • This company is making money at a decent rate.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the TCMD Numbers

TCMD Price
(Tactile Systems Technology stock price per share)
$25.60
[?] TCMD Fair Price
(based on intrinsic value)
$9.77
[?] TCMD Safety Price (based on a variable margin of safety) $5.86
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 22% higher than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Medical Devices stocks
[?] Free Cash Flow Jitter 99%

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 2,788,674 shares shorted. With 19,678,934 shares available for purchase and an average trading volume over the past 10 trading days of 196,010, it would take at least 14.2 days for all of the short holders to cover their shorts.

What does this mean to you? At this volume, it'll take more than two trading weeks for shorts to cover. This may indicate a short squeeze play would work! If this stock has good fundamentals and it'll take a while for the short holders to cover, buying now could net you bigger short-term technical gains if and as the price rises.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2014 1027838 -1.3
2015 1027838 1.9
2016 1027838 6.5
2017 1027838 2.8
2018 1027838 7.1
2019 1027838 -0.4
2020 1027838 -0.5
2021 1027838 -0.9
2022 1027838 2.1
2023 1027838 33.1
2024 1027838 38.5
2025 1027838 40.6

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 9 fiscal years from 2014 to 2025 with positive net income, operating cash flow totaled $143 million against net income of $94.4 million, or 1.52 times. Net income was negative in 3 of the 12 years, and those years are left out of the ratio.

In 2025, operating cash flow was 2.24 times net income, compared with 1.33 times for the earliest three years (2014 to 2016).

In 2025, capital expenditures were $2.4 million, 5.6% of operating cash flow of $42.8 million, which leaves an estimated $40.4 million after capex. Across the 11 years with reported capex, it averaged 17.9% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2014 2.1 -1 0.4 -0.48
2015 1.4 2.4 0.6 1.72
2016 2.9 7 0.8 2.44
2017 5.9 4.2 3.7 0.72
2018 6.6 9 4.2 1.36
2019 11 2.5 5.4 0.23
2020 -0.6 2.8 2.1 n/a
2021 -11.8 2.6 2.1 n/a
2022 -17.9 5.2 1.8 n/a
2023 28.5 35.9 2.3 1.26
2024 17 40.7 2.4 2.40
2025 19.1 42.8 2.4 2.24

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 3 fiscal years from 2017 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $82 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In 3 of the 3 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $30.6 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2025, cash spent repurchasing shares was $26.6 million, 65.4% of estimated free cash flow of $40.6 million.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2017 2.8 n/a 0.5 0.5 17.4%
2024 38.5 n/a 3.5 3.5 9.1%
2025 40.6 n/a 26.6 26.6 65.4%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $47.7 million in 2014 and $330 million in 2025, a compound annual growth rate of 19.2% over 11 years.

Revenue rose 12.5% from 2024 to 2025.

Our estimated free cash flow was $40.6 million in 2025, 12.3% of revenue. In 2014 the estimated margin was negative 2.8%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2014 47.7 -1.3 -2.8%
2015 62.9 1.9 3.1%
2016 84.5 6.5 7.6%
2017 109 2.8 2.6%
2018 144 7.1 4.9%
2019 189 -0.4 -0.2%
2020 187 -0.5 -0.2%
2021 208 -0.9 -0.4%
2022 247 2.1 0.8%
2023 274 33.1 12.1%
2024 293 38.5 13.1%
2025 330 40.6 12.3%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $83.4 million against total liabilities of $55 million, or 151.6% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 20.1% of total assets in 2025, compared with 115.3% in 2015, a decrease of 95.2 percentage points.

Stockholders equity was $219 million in 2025, up from negative equity of -$5.6 million in 2015.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 27.2% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2015 37 7.1 42.6 -5.6
2016 73.9 30.7 14.3 59.6
2017 88.4 24 15.7 72.8
2018 107 20.1 17.8 89.3
2019 152 22.8 39.2 113
2020 174 47.9 49.3 125
2021 244 28.2 116 128
2022 255 21.9 134 121
2023 281 61 87.8 194
2024 298 94.4 81.3 217
2025 274 83.4 55 219

Price Versus Our Estimated Value

Of the 12 fiscal years we can see for Tactile Systems Technology under its current filer, 8 show positive free cash flow.

Our fair value estimate for Tactile Systems Technology is $9.77, below its current price of $25.60.

Free cash flow from the first three years of data averaged $2.3 million, and from the last three $37.4 million: a sharp rise.

Free cash flow is volatile from year to year, with a variability measure of 99%.

Dividends are not in our data for Tactile Systems Technology.

These numbers change when new filings or prices arrive, so treat this page as a snapshot and check the company's own filings.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 22% above the average for stocks in the Healthcare sector.

Its trailing P/E ratio is in line with the average for stocks in the Medical Devices industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

Closest Industry Peers

These are companies in the Medical Devices industry, the ones closest in market capitalization to Tactile Systems Technology, limited to companies whose pages we publish. The figures come from our latest data for each company.

CompanyMarket cap (USD millions)P/EDividend yieldCash yieldPrice versus our estimate
Tactile Systems Technology (TCMD) 573 24.9 - - 162% above
InfuSystem Holdings (INFU) 287 32.6 - - 402% above
Utah Medical Products (UTMD) 198 20.8 1.7% 7.0% 75% below
Electromed (ELMD) 188 16.7 - - 248% above
IRadimed Corporation (IRMD) 1,036 43.3 1.0% - 995% above
CONMED Corporation (CNMD) 1,382 19.2 - 5.6% 35% below
LeMaitre Vascular (LMAT) 1,684 27.1 1.3% - 328% above

Industry labels are approximate, and companies in one industry can run quite different businesses, so a peer may not be a close match.

Ratios on different fiscal calendars are not strictly comparable, and a trailing P/E can be distorted by one-time items.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 1027838.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • Free cash flow was negative in 4 of the 12 years we have.
  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-20
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: TCMD annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in TCMD

Does Tactile Systems Technology have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: TCMD

This example shows how we apply the Trendshare checklist to TCMD: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 25.60
    • Market cap: $573M
    • EPS: 1.03
  2. Step 2 — Valuation checks

    • P/E: 24.854
    • FCF yield: —
    • Date checked: Nov 20, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.